Myovant Sciences Ltd.


Get free email notifications about news in Myovant Sciences Ltd..

The service is free and you can unsubscribe at any time.

General | People (33) | Filings (79) | Annual reports (1) | Stock | News


CIK Number: 0001679082

Myovant Sciences Ltd. is a publicly traded company

Trading symbol: MYOV



Strength Seen in Myovant Sciences (MYOV): Stock Soars 16.1%
Yahoo Finance
Myovant Sciences Ltd. MYOV was a big mover last session, as the company saw its shares rise over 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.


Super-hot Biopharma stock: Myovant Sciences Ltd (NYSE: MYOV)
FX Daily Report
Myovant Sciences Ltd (NYSE: MYOV) stock is going gangbusters today and generated over 15.9% today (as of 3:08PM EDT on August 17th, 2017; Source: Google finance). Evercore ISI analysts are bullish on the stock and gave an “Outperform” rating with a ...
Is Evercore ISI Group Positive On Shares of Myovant Sciences Ltd. Common ... - WeeklyHub
Myovant Sciences Ltd (MYOV) Receives $19.50 Average PT from Brokerages - StockNewsTimes


Mid-Day Market Update: Briggs & Stratton Drops On Q4 Miss; Myovant Sciences ...
Shares of Stage Stores Inc (NYSE: SSI ) got a boost, shooting up 25 percent to $1.89. Stage Stores reported Q2 adjusted loss of $0.15 per share on sales of $377.1 million.
Mid-Afternoon Market Update: Dow Falls 180 Points; Stage Stores Shares Spike ... - Benzinga


Myovant Sciences Ltd. (MYOV) Trades at 52-Week High
Modern Readers
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders.
Could Myovant Sciences Ltd (MYOV) See a Reversal After This Very Weak Session? - Press Telegraph


What's Myovant Sciences Limited (NYSE:MYOV) Upside After This Short Interest ...
BZ Weekly
The stock of Myovant Sciences Limited (NYSE:MYOV) registered an increase of 16.78% in short interest. MYOV's total short interest was 638,800 shares in August as published by FINRA.


Analysts Set Myovant Sciences Ltd (NASDAQ:MYOV) Price Target at $19.50
BNB Daily (blog)
Myovant Sciences logo Shares of Myovant Sciences Ltd (NASDAQ:MYOV) have been assigned a consensus rating of “Buy” from the six ratings firms that are currently covering the company, MarketBeat.
13116 Shares in Myovant Sciences Ltd (MYOV) Acquired by Quantitative ... - Rincon Hill News
Myovant Sciences Ltd (MYOV) Given Average Recommendation of “Buy” by Brokerages - Chaffey Breeze


Myovant Sciences Provides Corporate Update and Reports Financial Results for ...
PR Newswire (press release)
BASEL, Switzerland, Aug. 10, 2017 /PRNewswire/ -- Myovant Sciences (NYSE: MYOV), a leading clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women's health and endocrine diseases, today ...
Head-To-Head Review: Myovant Sciences (MYOV) and Biogen (BIIB) - Week Herald
Myovant Sciences Ltd. (NYSE:MYOV) Files An 8-K Results of Operations and ... - Market Exclusive

Myovant Sciences Ltd. address


Earliest known filing

July 2016

Latest known filing

August 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

Myovant Sciences Ltd. has 79 filings. View Myovant Sciences Ltd. filings.

Annual Reports

Quarterly Reports

Latest company events


We have found 33 people related to Myovant Sciences Ltd..